Cotización Gamida Cell - GMDA | ADVFN

US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Gamida Cell Ltd (GMDA) Cotización

Gamida Cell Ltd (GMDA)

0.0327

0.00

(0.00%)

Cerrado 25 Diciembre 3:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

Fuera de horario: -

Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Último Precio

0.0327

Postura de Compra

0.0302

Postura de Venta

0.0304

Volume Operado de la Acción

-

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Precio Anterior

0.0327

Precio de Apertura

-

Hora

Última hora de negociación

Volumen promedio (3 m)

-

Volumen financiero

-

Precio Promedio Ponderado

-

HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200

Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial OfficerCompany is conducting a review of its business...

XORTX Welcomes New Member to the Board of Directors

CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical...

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

WARREN, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

GMDA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Gamida Cell?

El precio actual de las acciones de Gamida Cell es US$ 0.0327

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Gamida Cell?

Gamida Cell ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
BAOSBaosheng Media Group Holdings Ltd	US$ 7.10 (310.40%)	58.74M
HOURHour Loop Inc	US$ 4.40 (207.69%)	97.42M
GTIGraphjet Technology	US$ 0.61 (168.72%)	265.48M
CREVCarbon Revolution Public Ltd	US$ 9.16 (135.48%)	26.95M
AVGRAvinger Inc	US$ 1.45 (125.72%)	107.53M
SLGLSol Gel Technologies Ltd	US$ 0.9798 (-40.62%)	3.07M
DRCTDirect Digital Holdings Inc	US$ 3.71 (-32.55%)	23.82M
CHEKCheck Cap Ltd	US$ 1.55 (-31.11%)	3.49M
SYTASiyata Mobile Inc	US$ 0.5178 (-30.83%)	2.63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF	US$ 15.47 (-30.38%)	147.98k
SVMHSRIVARU Holding Ltd	US$ 0.0338 (20.71%)	280.27M
GTIGraphjet Technology	US$ 0.61 (168.72%)	265.48M
LITMSnow Lake Resources Ltd	US$ 0.5849 (52.84%)	181.22M
LCIDLucid Group Inc	US$ 3.20 (3.23%)	108.75M
RGTIRigetti Computing Inc	US$ 11.35 (3.56%)	108.38M

dukeb

dukeb 3 minutos hace

LOL. Next you're going to tell me that the jambalaya I had at the Minnesota State Fair that included fried Twinkies in it wasn't true to the Louisiana original recipe.

Charleys Philly Steaks founder and CEO Charley Shin tasted his first Philly Cheesesteak back in 1985 while attendin

Value_Investor

Value_Investor 5 minutos hace

The premarket-session (before 9:30 AM) high on 12/17/24 was $1.94 which is $0.24 higher than your selling price! However, after 9:30 AM in the regular trading session (between 4:00 PM and 9:30 AM) the high was only $1.30 !

Anyway, TNXP will easily bounce back to $1.94 again after

nowwhat2

nowwhat2 6 minutos hace

Gong Show

https://investorshub.advfn.com/uimage/uploads/2024/12/25/sqmcsbtc_121212_25_15d_530pm_100K_GONG_SHOW.jpg

https://investorshub.advfn.com/uimage/uploads/2024/12/25/sru[ybtc_121212_25_45d_410pm_BUSTOUT_INEVITABLE.jpg

tbonaces80

tbonaces80 6 minutos hace

We go hard this week. Too many Capital firms bought in. Load the boat $6-$10 easy

Top Penny

Top Penny 11 minutos hace

onehundredmph

onehundredmph 11 minutos hace

Lol. Liquidity is drying up fast. Don't play stupid. Tic tok

Top Penny

Top Penny 11 minutos hace

$300 PPS someday

Top Penny

Top Penny 11 minutos hace

Top Penny

Top Penny 11 minutos hace

IBIO will be my main holding going forward!

Riley4

Riley4 12 minutos hace

It’s 100%. No drug with almost no adverse effects is declined. Now what happens behind the scenes 🤷‍♂️ but will be approved, no matter what khyber pass hero says

delerious1

delerious1 12 minutos hace

And.....the second best thing about NBRI is that there are so many Fundamental drivers coming up that it will be hard for new retail traders to ignore

Steady_T

Steady_T 13 minutos hace

Missling has said no meetings with the FDA until the paper is published. Some here has suggested that there won't be an FDA filing until the draft guidance becomes final guidance.

That suggests to me that the FDA filing will be no earlier than Feb or Mar. (guess). Unless the NDA is g

Tiger Money

Tiger Money 14 minutos hace

If you want to make real money. You hold

nathanial

nathanial 18 minutos hace

One would think that the FDA is aware of the 5 successful patients in India and start moving the ball forward here in the USA. Enough of the sprint meetings and followup questions.

skitahoe

skitahoe 19 minutos hace

Never is a very long time. I've believed many products were certain of approval in my lifetime. In a couple cases the regulator did delay them, but all that I felt certain of were eventually approved. I've felt certain that DCVax-L would eventually be approved, I still believe the chance is great

Jp_SHMP

Jp_SHMP 19 minutos hace

We should see the whale and the crow
It's getting hot

Road to greatness

bar1080

bar1080 20 minutos hace

Closing 1200 Walgreens stores will cost a fortune in impairments. I worry too when I see terms like Adjusted earnings per share.

Riley4

Riley4 23 minutos hace

Take it back to the Khyber pass, lol, lol 😂

kennyt 335

kennyt 335 23 minutos hace

Sorry NASDAQ2020 •EVA

jaramill

jaramill 24 minutos hace

TRUMP-EFFECT==$HHSE ready to EXPLODE to the upside. They are partnered with Trump Media ($DJT) on the "Trump-Book" AMERICAN MANIFESTO.

Thanks to all HHSE longs who stuck it out during the tough times. BIG rewards are finally coming, mainly due to the CEO's HARD WORK and TENACITY, navi

DJT HHSE MILLION

Whalatane

Whalatane 24 minutos hace

Happy Holidays Dew , many thx to you and the other contributors here , for all your informed insights
Kwi

janice shell

janice shell 25 minutos hace

Bin Tuberville along with Trump. He's so stupid he'll never notice he's in the nuthouse.

delerious1

delerious1 25 minutos hace

NeutrinoKid

NeutrinoKid 28 minutos hace

This just in: New market report mentioning RespireRx:

Global Circadian Rhythm Sleep Disorder Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
Publisher: Maia Research
Published Date: Dece

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones